biomedicina slovenica


pr=Brguljan : 101-200

  1. Hojs Radovan; Gorenjak Maksimiljan; Krsnik Mladen; Lainščak Mitja; Lindič Jelka; Meško Brguljan Pika; Možina Barbara; Zaletel Jelka
    Presejalne metode za kronično ledvično bolezen: ocena glomerulne filtracije
    2009
  2. Lindič Jelka; Flisar Živa; Krsnik Mladen; Gorenjak Maksimiljan; Hojs Radovan; Lainščak Mitja; Meško-Brguljan Pika; Možina Barbara; Zaletel-Vrtovec Jelka
    Presejalne metode za kronično ledvično bolezen: ocena proteinurije in albuminurije
    2009
  3. Hojs Radovan; Gorenjak Maksimiljan; Krsnik Mladen; Lainščak Mitja; Lindič Jelka; Meško-Brguljan Pika; Možina Barbara; Zaletel-Vrtovec Jelka
    Presejalne metode za kronično ledvično bolezen: ocena glomerulne filtracije
    2009
  4. Možina Barbara; Meško-Brguljan Pika
    Dobrodošlica
    [Welcome]
    2008
  5. Karakaš N; Dvoršak K; Meško-Brguljan P
    Prenova nabavnega procesa v Laboratoriju za klinično biokemijo in hematologijo Bolnišnice Golnik - KOPA
    [Modernization of the purchase process in the Laboratory for clinical chemistry and hematology of the University clinic of pulmonary and allergic diseases Golnik]
    2008
  6. Karakaš N; Graiser N; Meško-Brguljan P
    Vloga laboratorija pri zagotavljanju kakovosti predanalitske faze
    [The role of the medical laboratory in quality assurance of the preanalytical phase]
    2008
  7. Sekne J; Sušnik M; Meško-Brguljan P
    Psevdotrombocitopenija
    [Pseudotrombocytopenia]
    2009
  8. Meško-Brguljan Pika
    Plinska analiza krvi
    2008
  9. Meško-Brguljan Pika
    Foreword
    2008
  10. Meško-Brguljan P; Kern I; Košnik M; Cimerman N
    Cysteine proteases and their inhibitors in syndrome of airway obstruction
    2008
  11. Bratož Saša; Kobe Modrica-Jasna; Krhin Blaž; Meško-Brguljan Pika; Možina Barbara; Pungertnik Darja
    Končni program 3. slovenski kongres klinične kemije z mednarodno udeležbo, 3. slovenski kongres tehnikov laboratorijske medicine, 18. mednarodni simpozij Slovenskega združenja za klinično kemijo in Hrvatskog društva medicinskih biokemičara; 2008 nov 13-15; Ljubljana
    [Final programme of the 3rd Slovenian congress of clinical chemistry with international participation, 3rd Slovenian congress of laboratory medicine technicians, 18th international symposium of Slovenian association for clinical chemistry and Croatian society of medical biochemists; 2008 Nov 13-15; Ljubljana]
    2008
  12. Meško-Brguljan Pika; Božič Borut; Bratož Saša
    Implementation of bylaw regulations on laboratory medicine in Slovenia
    2008
  13. Kobe Jasna Modrica; Homšak Evgenija; Krhin Blaž; Meško-Brguljan Pika; Pungertnik Darja
    Zbornik strokovnih prispevkov 3. slovenski kongres tehnikov laboratorijske medicine; 2008 nov 13-15; Ljubljana
    2008
  14. Sabotin M; Mrhar A; Meško-Brguljan P
    Drug dosage regimen adjustment in patients with kidney failure according to estimations of glomerular filtration rate
    2008
  15. Marc-Malovrh Mateja; Veternik-Debeljak Ana; Meško-Brguljan Pika; Lainščak Mitja
    NT-proBNP and left ventricular dysfunction in patients with deteriorated chronic obstructive pulmonary disease: a preliminary study
    2008
  16. Accetto Rok; Brguljan-Hitij Jana; Dobovišek Jurij; Dolenc Primož; Salobir Barbara
    Slovenske smernice za zdravljenje arterijske hipertenzije 2007
    2008
  17. Brguljan-Hitij Jana
    Bolečina v prsnem košu - kaj sedaj?
    2008
  18. Accetto Rok; Rener Karla; Brguljan-Hitij Jana; Salobir Barbara
    Clinical implication of pulse wave analysis
    2007
  19. Karakaš N; Meško-Brguljan P
    Today's medical laboratory brings new challenges
    [Suvremeni medicinski laboratorij donosi nove izazove]
    2007
  20. Meško-Brguljan Pika; Cimerman Nina
    Human cystain C
    2007
  21. Meško-Brguljan Pika
    The initial experiences in adulting of quality management implementation in Slovenia
    2007
  22. Meško-Brguljan Pika
    Laboratorijska medicina podprta z dokazi - izziv za prihodnost?
    2006
  23. Accetto Rok; Brguljan-Hitij Jana
    Zdravljenje hipertenzijskih nujnih stanj
    [Management of hypertensice emergencies]
    2007
  24. Meško-Brguljan P; Košnik M; Cimerman Nina
    Cysteine proteinases and their inhibitors in bronchial inflammation and variable airway obstruction
    2007
  25. Bratož S; Prezelj M; Meško-Brguljan P
    Slovenian approach to POCT management
    2007
  26. Topić Elizabeta; Meško-Brguljan Pika; Blaton Victor
    New trends in classification, monitoring and management of metabolic syndrome. Handbook of the 6th FESCC continuous postgraduate course in clinical chemistry under the auspices of IFCC; 2006 Nov 11-12; Dubrovnik
    2006
  27. Meško-Brguljan Pika; Popovič T; Brzin J; Cimerman N; Križaj I; Ritonja A; Turk V
    Human brain cathepsin H: isolation, characterization and specificity
    1995
  28. Guder W; Stavljenić A; Meško-Brguljan P; Gonano F; Hagemann P; Horvath AR; Mueller M; Palicka V; Reinauer H; Voght W
    Quality standards in the Alps-Adria laboratories
    2004
  29. Brguljan-Hitij Jana
    Pomen sartanov v zdravljenju arterijske hipertenzije
    2006
  30. Brguljan-Hitij Jana
    Neželeni učinki najpogostejših kombinacij zdravil
    2006
  31. Bratož Saša; Meško-Brguljan Pika; Možina Barbara
    Obvestilo 2. slovenski kongres klinične kemije z mednarodno udeležbo, 16. mednarodni simpozij Slovenskega združenja za klinično kemijo in Hrvatskog društva medicinskih biokemičara, 2. slovenski kongres tehnikov laboratorijske medicine; 2004 okt 15-16; Maribor
    [Announgement of the 2nd Slovenian congress of clinical chemistry with international participation, 16th international symposium of Slovenian association for clinical chemistry and Croatian society of medical biochemists, 2nd Slovenian congress of laboratory medicine technicians; 2004 Oct 15-16; Maribor]
    2004
  32. Bratož Saša; Meško-Brguljan Pika; Možina Barbara
    Končni program 2. slovenski kongres klinične kemije z mednarodno udeležbo, 16. mednarodni simpozij Slovenskega združenja za klinično kemijo in Hrvatskog društva medicinskih biokemičara, 2. slovenski kongres tehnikov laboratorijske medicine; 2004 okt 15-16; Maribor
    [Final programme of the 2nd Slovenian congress of clinical chemistry with international participation, 16th international symposium of Slovenian association for clinical chemistry and Croatian society of medical biochemists, 2nd Slovenian congress of laboratory medicine technicians; 2004 Oct 15-16; Maribor]
    2004
  33. Marc Janja; Meško-Brguljan Pika; Možina Barbara
    Končni program 1. slovenski kongres klinične kemije z mednarodno udeležbo; 2000 6-7 okt; Portorož
    2000
  34. Meško-Brguljan Pika
    Vpliv predanalitskih dejavnikov na kakovost laboratorijskih izvidov
    2006
  35. Brguljan-Hitij Jana
    Kaj nam povedo elektrolitske spremembe pri hipertoniku
    [Electrolytic changes in hypertensive patient]
    2006
  36. Božič Borut; Meško-Brguljan Pika; Bratož Saša
    Pravilnik o pogojih, ki jih morajo izpolnjevati laboratoriji za izvajanje preiskav na področju laboratorijske medicine: priročnik; 2005 mar 25; 2005 apr 1; 2005 maj 24; Ljubljana
    2005
  37. Meško-Brguljan P; Cimerman N
    Cystatin C - creatinine relation in asthma
    2004
  38. Meško-Brguljan Pika
    Quality standards in Slovenian medical laboratories
    2004
  39. Meško-Brguljan P; Bratož S
    The ongoing process of quality standard implementation in Slovenian medical laboratories
    2005
  40. Brguljan-Hitij Jana; Accetto Rok
    Kakovost življenja z arterijsko hipertenzijo
    2004
  41. Salobir Barbara; Brguljan-Hitij Jana
    Izboljšanje življenjskega sloga pri hipertenziji
    2004
  42. Brguljan-Hitij Jana; Pirc-Čerček Olga
    Nesteroidni antirevmatiki in arterijska hipertenzija
    2004
  43. Meško-Brguljan Pika; Šuškovič Stanislav; Cimerman Nina
    Cystatin C in asthma
    2004
  44. Karakaš N; Tomič V; Meško-Brguljan P
    CRP in prokalcitonin pri bolnikih v enotah intenzivne terapije
    [CRP and procalcitonin in patients admitted to intensive care unit]
    2004
  45. Meško-Brguljan P; Cimerman N
    The effect of methylprednisolone and cyclosporine A therapy on serum cystatin C
    2004
  46. Meško-Brguljan P; Cimerman N
    Is serum cystatin C a suitable marker for GFR deterioration in asthma?
    2004
  47. Meško-Brguljan Pika
    Beseda gostujoče urednice
    [Guest editor's preface]
    2004
  48. Meško-Brguljan Pika
    Zbornik razširjenih povzetkov 2. slovenski kongres klinične kemije z mednarodno udeležbo, 16. mednarodni simpozij Slovenskega združenja za klinično kemijo in Hrvatskog društva medicinskih biokemičara, 2. slovenski kongres tehnikov laboratorijske medicine; 2004 okt; Ljubljana
    [Proceedings from the congress of the 2nd Slovenian congress of clinical chemistry with international participation, 16th international symposium of Slovenian association for clinical chemistry and Croatian society of medical biochemists, 2nd Slovenian congress of laboratory medicine technicians; 2004 Oct; Ljubljana]
    2004
  49. Škrgat-Kristan S; Meško-Brguljan P; Košnik M; Šorli J
    D-dimer in the diagnosis of pulmonary embolism
    2003
  50. Meško-Brguljan Pika; Turk Vito; Cimerman Nina; Brzin Jože; Križaj Igor; Popovič Tatjana
    Breakdown of neuropeptides by human brain cathepsin H
    2004
  51. Cimerman Nina; Košnik Mitja; Kern Izidor; Kos Janko; Meško-Brguljan Pika
    Cystatin C, inhibitor of cysteine proteinases, in asthma
    2004
  52. Meško-Brguljan Pika; Turk Vito; Cimerman Nina; Brzin Jože; Križaj Igor; Popovič Tatjana
    Human brain cathepsin H as a neuropeptide and bradykinin metabolizing enzyme
    2003
  53. Škrgat-Kristan Sabina; Meško-Brguljan Pika; Košnik Mitja; Šorli Jurij
    D-dimer is of limited value in the diagnosis of pulmonary embolism
    2003
  54. Cimerman Nina; Košnik Mitja; Kern Izidor; Kos Janko; Meško-Brguljan Pika
    Cystatin C in asthma - concentration, immunoblot and immunohistochemical analysis
    2003
  55. Meško-Brguljan Pika; Turk Vito; Cimerman Nina; Brzin Jože; Križaj Igor; Popovič Tatjana
    Breakdown of neuropeptides by human brain cathepsin H
    2003
  56. Kern I; Urbanc T; Meško-Brguljan P; Cimerman N
    Immunolocalisation of cysteine proteinases and their inhibitors in asthma
    2003
  57. Meško-Brguljan P; Kern I; Kos J; Košnik M; Cimerman N
    Cystatin C concentration and immunolocalisation in asthma
    2003
  58. Meško-Brguljan P; Kern I; Urbanc T; Kos J; Košnik M; Cimerman N
    Cystatin C concentration and immunolocalisation in asthma
    2003
  59. Cimerman Nina; Košnik Mitja; Kern Izidor; Kos Janko; Meško-Brguljan Pika
    Cystatin C in asthma
    2003
  60. Meško-Brguljan P; Šuškovič S; Kos J; Krašovec M; Cimerman N
    Serum cystatins and cathepsins in relation to markers of airway inflammation and obstruction in patients with asthma
    2002
  61. Cimerman Nina; Kos Janko; Krašovec Marta; Košnik Mitja; Meško-Brguljan Pika
    Cysteine proteinases and their inhibitors in induced sputum samples from healthy subjects and asthmatic patients
    2002
  62. Meško-Brguljan Pika; Bratož Saša
    Sistem kakovosti v klinično kemjiskih laboratorijih v Sloveniji
    [Quality system in clinical chemistry laboratories in Slovenia]
    2002
  63. Meško-Brguljan Pika
    Uvodnik
    [Editorial]
    2002
  64. Meško-Brguljan Pika; Možina Barbara
    Kakovost in akreditacija medicinskih laboratorijev v Sloveniji in Evropski uniji: priročnik
    [Quality and accrediation of medical laboratories: state-of-the-art in Slovenia and European union: handbook]
    2002
  65. Cimerman Nina; Meško-Brguljan Pika; Krašovec Marta; Šuškovič Stanislav; Kos Janko
    Circadian rhythms of cysteine proteinases and cystatins, potential tumour markers, in normal sera
    2002
  66. Brguljan-Hitij Jana; Marn-Pernat Andreja
    Klinične raziskave z zaviralci angiotenzinske konvertaze
    1999
  67. Meško-Brguljan P; Krašovec M; Šuškovič S; Kos J; Cimerman N
    Balance in asthma between serum cysteine proteinases and their inhibitors
    2002
  68. Meško-Brguljan Pika; Bratož Saša
    Quality and accreditation of clinical chemistry laboratories: state-of-the-art in Slovenia
    2002
  69. Cimerman Nina; Meško-Brguljan Pika; Krašovec Marta; Šuškovič Stanislav; Kos Janko
    Cysteine proteinases and cystatins - potential role in asthma
    2001
  70. Cimerman Nina; Meško-Brguljan Pika; Krašovec Marta; Šuškovič Stanislav; Kos Janko
    Serum concentration and circadian profiles of cathepsin B, H and L, and their inhibitors, stefins A and B, in asthma
    2001
  71. Cimerman Nina; Meško-Brguljan Pika; Krašovec Marta; Šuškovič Stanislav; Kos Janko
    Induced sputum concentrations of cysteine proteinases and low molecular weight cystatins from healthy subjects and asthmatic patients
    2001
  72. Cimerman Nina; Meško-Brguljan Pika; Krašovec Marta; Šuškovič Stanislav; Kos Janko
    Circadian and concentration profile of cathepsin S in sera from healthy subjects and asthmatic patients
    2001
  73. Cimerman N; Meško-Brguljan P; Krašovec M; Šuškovič S; Kos J
    Assessment of cathepsin and custatin concentrations in serum and induced sputum samples from asthmatic patients
    2001
  74. Cimerman Nina; Meško-Brguljan Pika; Krašovec Marta; Šuškovič Stanislav; Kos Janko
    Circadian variations of serum cysteine proteinases and cystatins and their assessment in asthma
    [Cirkadiane variacije cisteinskih proteinaz in cistatinov v serumu in njihov pomen pri astmi]
    2000
  75. Cimerman Nina; Meško-Brguljan Pika; Šuškovič S; Krašovec M; Kos J
    Circadian rhythms of cystatin C and sera cystatin C values in asthma
    1996
  76. Meško-Brguljan Pika; Kos Jamko; Šuškovič Stanislav; Krašovec Marta; Cimerman Nina
    Cathepsin S and cystatin C in sera of asthmatic patients
    2000
  77. Cimerman N; Meško-Brguljan P; Krašovec M; Šuškovič S; Kos J
    Circadian variation of chatepsin S in sera from helathy subjects and asthmatic patients
    2000
  78. Cimerman Nina; Meško-Brguljan Pika; Krašovec Marta; Šuškovič Stanislav; Kos Janko
    Serum cystatin C is elevated in asthmatic patients
    2000
  79. Cimerman Nina; Meško-Brguljan Pika; Krašovec Marta; Šuškovič Stanislav; Kos Janko
    Serum cystatin C, a potent inhibitor of cysteine proteinases, is elevated in asthmatic patients
    2000
  80. Cimerman N; Brguljan-Meško P; Krašovec M; Šuškovič S; Kos J
    Circadian rhythms of cysteine proteinases and cystatins, potential markers for disease, in normal sera
    2000
  81. Cimerman N; Meško-Brguljan P; Krašovec M; Šuškovič S; Kos J
    Cysteine proteinases and cystatins in normal and asthmatic sera: concentration and circadian profiles
    2000
  82. Meško-Brguljan P; Krašovec M; Šuškovič S; Kos J; Cimerman N
    Serum cystatin C compared to creatinine in asthmatic patients
    2000
  83. Cimerman Nina; Meško-Brguljan Pika; Krašovec Marta; Šuškovič Stanislav; Kos Janko
    Twenty-four hour variations of cystatin C and total cysteine proteinase inhibitors activity in sera from healthy subjects
    2000
  84. Škrgat-Kristan Sabina; Meško-Brguljan Pika; Košnik Mitja; Šorli Jurij
    D-dimer v diagnostiki pljučne embolije
    [D-dimer in the diagnostic procedure of pulmonary embolism]
    1999
  85. Cimerman Nina; Meško-Brguljan Pika; Krašovec Marta; Šuškovič Stanislav; Kos Janko
    Cysteine proteinases and cystatins in asthma
    1999
  86. Cimerman NC; Meško-Brguljan PMB; Krašovec MK; Šuškovič ; Kos JK
    Biological variations of serum cysteine proteinases and their inhibitors in healthy and asthmatic subjects - effect of corticosteroid and cyclosporin treatment
    1999
  87. Cimerman N; Brguljan-Meško P; Krašovec M; Šuškovič S; Kos J
    Relevance of serum levels and circadian structure of cathepsins and cystatins in asthma
    1999
  88. Cimerman Nina; Meško-Brguljan Pika; Krašovec Marta; Šuškovič Stanislav; Kos Janko
    Cicardian characteristics of cathepsins B, H, L, and stefins A and B, potential markers for disease, in normal sera
    1999
  89. Cimerman N; Meško-Brguljan P; Krašovec M; Šuškovič S; Kos J
    Circadian variations of serum cystatin C in healthy and asthmatic subjects - efect of corticosteroid and cyclosporin treatment
    1998
  90. Cimerman N; Brguljan-Meško P; Krašovec M; Šuškovič S; Kos J
    The influence daily variation on the sampling of serum cathepsins and their inhibitors
    1998
  91. Meško-Brguljan P; Cimerman N; Šuškovič S; Krašovec M; Kos J
    Elevated levels of serum cystatin C in asthma
    1997
  92. Cimerman N; Meško-Brguljan P; Šuškovič S; Krašovec M; Schweiger A; Kos J
    Twenty four hour patterns of serum cathepsins B, H, L and cystatin C in normal subjects
    1997
  93. Meško-Brguljan Pika; Cimerman N; Šuškovič S; Krašovec M; Kos J
    Variations of cystatin C in serum of asthmatics over 24 hours
    1997
  94. Cimerman N; Meško-Brguljan P; Šuškovič S; Krašovec M; Schweiger A; Kos J
    Circadian charactersitics of serum cathepsin B, H, L and cystatin C
    1997
  95. Dolenc Primož; Jezeršek Pavle; Accetto Rok; Brguljan Jana; Salobir Barbara
    Influence of activities and emotional stress on ambulatory blood pressure
    1996
  96. Cimerman N; Krašovec M; Meško-Brguljan P; Schweiger A; Šuškovič S; Kos J
    Serum changes of potential tumor markers cystatin C and cathepsins B, H and L over twenty four hours
    1997
  97. Cimerman N; Meško-Brguljan P; Krašovec M; Šuškovič S; Schweiger A; Kos J
    24 hour changes of cathepsins B, H, L, and cystatin C levels in normal and asthmatic sera
    1997
  98. Cimerman N; Meško-Brguljan P; Šuškovič S; Krašovec M; Schweiger A; Kos J
    Fluctuations in serum levels of cathepsins B, H, L and cystatin C during 24 hours
    1997
  99. Cimerman N; Meško-Brguljan P; Šuškovič S; Krašovec M; Kos J
    Cystatin C concentrations in human sera: relationship to asthma
    1997
  100. Dolenc Primož; Jezeršek Pavle; Accetto Rok; Brguljan Jana; Salobir Barbara
    Influence of activities and emotional stress on ambulatory blood pressure
    1996

   1 101 201  


New search      Comments      Top of page Institute for Biostatistics and Medical Informatics